A Christchurch neurologist is describing a new drug being trialled on multiple sclerosis sufferers as a dream.
Doctor Deborah Mason, a consultant at Christchurch Hospital, is running one of a number of safety trials around the world for the drug Tysabri - a monoclonal antibody for the treatment of MS.
She has four patients on the trial and says they have all tolerated it very well.
Mason says there is mounting evidence Tysabri has the potential to keep patients in the early stages of the disease from progressing.
Advertisement
Her patients have all so far remained at the mild end of the disease spectrum.
Multiple sclerosis us a chronic, unpredictable disease of the central nervous system for which there is no known cure.
